tirzepatide cvot trial In patients with type 2 diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. Full SURPASS-CVOT results: https://nej.md/4qd5rLx Tirzepatide cardiovascular event risk assessment:

Learn why tirzepatide makes overeating uncomfortable and practical tips to manage food and side effects.

Find out if Tirzepatide is covered by Oscar Health, typical copay ranges, prior-auth rules, and affordable alternatives

Understanding realistic outcomes at this starter dose helps you plan your weight loss journey

have severe digestive problems or a history of pancreatitis, have untreated diabetic eye disease

FDA-approved as Zepbound (obesity) and Mounjaro (T2D)

Discover expert guidance on alcohol consumption with GLP-1 medications like Wegovy, Saxenda, and Mounjaro, including safety considerations, side effects, and UK clinical recommendations for optimal treatment outcomes.